Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

645
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
645
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

4.7K
GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
4.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

474
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
474
Allosteric Regulation01:08

Allosteric Regulation

58.3K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.3K
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

2.6K
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomolecular condensation of cMLCK enables myosin motor phosphorylation in the heart.

bioRxiv : the preprint server for biology·2026
Same author

Spatial control of myosin regulatory light chain phosphorylation modulates cardiac thick filament mechanosensing.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Development of bifunctional fluorescent probes and their application to α-helix labelling.

Organic & biomolecular chemistry·2025
Same author

Structural changes in troponin during activation of skeletal and heart muscle determined in situ by polarised fluorescence.

Biophysical reviews·2025
Same author

Cardiac myosin binding protein-C phosphorylation as a function of multiple protein kinase and phosphatase activities.

Nature communications·2024
Same author

Synthesis and Biophysical Characterization of Fingolimod Derivatives as Cardiac Troponin Antagonists.

ACS medicinal chemistry letters·2024

Related Experiment Video

Updated: Aug 2, 2025

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.5K

Conversion of a Cardiac Muscle Modulator from an Inhibitor to an Activator.

Fangze Cai1, Thomas Kampourakis2, Priyanka Parijat2

  • 1Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.

ACS Medicinal Chemistry Letters
|April 20, 2023
PubMed
Summary

Researchers explored how the aromatic core of W7 compounds affects cardiac muscle contraction. New dfbp-o core compounds with varying tails showed stronger binding and enhanced calcium sensitivity, highlighting cardiovascular system balance.

More Related Videos

Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity
12:52

Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity

Published on: March 5, 2020

8.3K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.3K

Related Experiment Videos

Last Updated: Aug 2, 2025

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.5K
Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity
12:52

Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity

Published on: March 5, 2020

8.3K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.3K

Area of Science:

  • Biochemistry
  • Cardiovascular Physiology
  • Molecular Pharmacology

Background:

  • Calcium binding to cardiac troponin C (cTnC) initiates muscle contraction by modulating troponin I (cTnI) interaction.
  • Modulators of sarcomere function often target the cTnC-cTnI interface, typically featuring an aromatic core and an aliphatic tail.

Purpose of the Study:

  • To investigate the role of the aromatic core in W7 compounds on cTnC modulation.
  • To synthesize and evaluate novel compounds (D-series) with a dfbp-o core and varying aliphatic tails.

Main Methods:

  • Synthesis of D-series compounds with a dfbp-o core and diverse tail lengths.
  • Binding affinity assessment using a cTnC-cTnI chimera (cChimera).
  • Measurement of calcium sensitivity in force generation and ATPase activity.

Main Results:

  • D-series compounds exhibited tighter binding to cChimera compared to analogous W-series compounds.
  • These novel compounds demonstrated increased calcium sensitivity of force generation.
  • Enhanced ATPase activity was observed, indicating improved calcium responsiveness.

Conclusions:

  • The aromatic core structure significantly influences the efficacy of cTnC modulators.
  • Compounds with the dfbp-o core and specific tail lengths offer improved calcium activation and binding.
  • These findings underscore the delicate balance within the cardiovascular system and potential therapeutic targets.